Aktar Rozina, Dietrich Antje, Tillner Falk, Kotb Shady, Löck Steffen, Willers Henning, Baumann Michael, Krause Mechthild, Bütof Rebecca
1 OncoRay ̶ National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf , Dresden , Germany.
2 German Cancer Consortium (DKTK), Partner Site Dresden , Dresden , Germany.
Br J Radiol. 2019 Mar;92(1095):20180539. doi: 10.1259/bjr.20180539. Epub 2018 Oct 11.
: Clinically relevant animal models of non-small cell lung carcinoma (NSCLC) are required for the validation of novel treatments. We compared two different orthotopic transplantation techniques as well as imaging modalities to identify suitable mouse models mimicking clinical scenarios.
: We used three genomically diverse NSCLC cell lines [National Cancer Institute (NCI)-H1703 adenosquamous cell carcinoma, NCI-H23 adenocarcinoma and A549 adenocarcinoma) for implanting tumour cells either as spheroids or cell suspension into lung parenchyma. Bioluminescence imaging (BLI) and contrast-enhanced cone beam CT (CBCT) were performed twice weekly to monitor tumour growth. Tumour histological data and microenvironmental parameters were determined.
: Tumour development after spheroid-based transplantation differs probably due to the integrity of spheroids, as H1703 developed single localised nodules, whereas H23 showed diffuse metastatic spread starting early after transplantation. A549 transplantation as cell suspension with the help of a stereotactic system was associated with initial single localised tumour growth and eventual metastatic spread. Imaging techniques were successfully applied to monitor longitudinal tumour growth: BLI revealed highly sensitive qualitative data, whereas CBCT was associated with less sensitive quantitative data. Histology revealed significant model-dependent heterogeneity in proliferation, hypoxia, perfusion and necrosis.
: Our developed orthotopic NSCLC tumours have similarity with biological growth behaviour comparable to that seen in the clinic and could therefore be used as attractive models to study tumour biology and evaluate new therapeutic strategies. The use of human cancer cell lines facilitates testing of different genomic tumour profiles that may affect treatment outcomes.
: The combination of different imaging modalities to identify tumour growth with subsequent use in treatment planning and orthotopic transplantation techniques to develop initially single lesions to ultimate metastases pave the way towards representative pre-clinical NSCLC models for experimental testing of novel therapeutic options in future studies.
新型治疗方法的验证需要具有临床相关性的非小细胞肺癌(NSCLC)动物模型。我们比较了两种不同的原位移植技术以及成像方式,以确定能够模拟临床情况的合适小鼠模型。
我们使用了三种基因不同的NSCLC细胞系[美国国立癌症研究所(NCI)-H1703腺鳞癌、NCI-H23腺癌和A549腺癌],将肿瘤细胞以球体或细胞悬液的形式植入肺实质。每周进行两次生物发光成像(BLI)和对比增强锥形束CT(CBCT)以监测肿瘤生长。确定肿瘤组织学数据和微环境参数。
基于球体移植后的肿瘤发展可能因球体的完整性而有所不同,因为H1703形成单个局限性结节,而H23在移植后早期就显示出弥漫性转移扩散。借助立体定向系统将A549作为细胞悬液进行移植,最初表现为单个局限性肿瘤生长,最终发生转移扩散。成像技术成功应用于监测肿瘤的纵向生长:BLI揭示了高度敏感的定性数据,而CBCT的定量数据敏感性较低。组织学显示在增殖、缺氧、灌注和坏死方面存在显著的模型依赖性异质性。
我们建立的原位NSCLC肿瘤在生物学生长行为上与临床所见相似,因此可作为研究肿瘤生物学和评估新治疗策略的有吸引力的模型。使用人类癌细胞系有助于测试可能影响治疗结果的不同基因组肿瘤谱。
结合不同成像方式以识别肿瘤生长,随后用于治疗规划,以及采用原位移植技术从最初的单个病变发展到最终的转移,为未来研究中新型治疗方案的实验测试建立具有代表性的临床前NSCLC模型铺平了道路。